Jagsonpal Pharmaceuticals Ltd logo

Jagsonpal Pharmaceuticals Ltd

JAGSNPHARM NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹1,235 Cr
Volatility
Moderate
P/E Ratio
30.3
Book Value
₹37.77
52W High
₹1,851.2
52W Low
₹1,548

Technical Indicators

Key Insights

Strengths

4
  • Company is almost debt free.
  • Company has delivered good profit growth of 38.2% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 46.0%
  • Debtor days have improved from 23.1 to 17.9 days.

Weaknesses

1
  • The company has delivered a poor sales growth of 11.1% over past five years.

Growth Rate

Revenue Growth
9.71% ↘
Net Income Growth
17.00% →
Cash Flow Change
-
ROE
19.00% ↗
ROCE
-
EBITDA Margin (Avg.)
-

Quarterly Results

  Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Depreciation 0000001222222
EPS in Rs 1.190.851.141.140.60.540.811.734.820.991.621.891.64
Expenses 52505249444151585850615857
Interest 0000000000000
Net Profit 867744511327111311
OPM % 14%10%14%14%7%6%17%22%21%15%19%22%22%
Operating Profit 9598331016169141616
Other Income 232232-22263331
PBT 107101055715399141715
Sales 60556058474361757459767473
Tax % 21%24%26%25%25%22%25%25%17%24%25%25%25%

Profit & Loss

  Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Depreciation 3332011121289
Div. Payout % 62%22%8%2%-2%9%17%15%56%49%59%30%—
EPS in Rs 0.320.180.51.81-1.761.11.22.62.884.083.48.346.14
Expenses 133129132138138157150169192203186218226
Interest 5453111100111
Net Profit 21312-1278171927225541
OPM % 7%6%8%4%-9%6%5%10%12%14%11%19%20%
Operating Profit 119126-1199192634235156
Other Income 001130134329289
PBT 32414-1299222735307054
Sales 144138143144127167159188218237209269282
Tax % 16%30%20%18%-1%20%16%22%29%23%25%21%—

Balance Sheet

  Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Borrowings 3639388845706999
CWIP 2000344000000
Equity Capital 13131313131313131313131313
Fixed Assets 5652522221222226232499490
Investments 0000001115511000
Other Assets 9810210812110511010912391170208184209
Other Liabilities 22192225232831353130212937
Reserves 85828597859198109120146174227240
Total Assets 156154159143130136147164164195217278299
Total Liabilities 156154159143130136147164164195217278299

Cash Flow

  Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
CFO/OP 755383-61431115016454158189124
Financing -4-1-6-34-1-6-1-7-180-9-12
Investing -10-241-3-1-11-2-26-58-25-45
Operating 849-3-23111287473555
Free Cash Flow 64640-53012286483591
Net Cash Flow 2215-624019-36-112-2

Ratios

  Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash Conversion Cycle 2592522923393251501647772485339
Days Payable 294260565459768276663537
Debtor Days 1151191061007345492526321918
Inventory Days 173176246295307164191134122826858
ROCE % 6%5%7%3%-10%9%9%18%20%25%17%23%
Working Capital Days 6468721541496755325934529

Shareholding Pattern

67.4%
30.3%
DIIs: 0.15% FIIs: 2.12% Promoters: 67.39% Public: 30.34%
  Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
DIIs 0.82% 0.82% 0.82% 0.82% 0.84% ↑0.00.84% 0.11% ↓0.70.00% ↓0.10.00% 0.05% ↑0.10.08% ↑0.00.15% ↑0.1
FIIs 0.10% 0.37% ↑0.30.38% ↑0.00.53% ↑0.20.73% ↑0.21.10% ↑0.42.30% ↑1.22.10% ↓0.22.10% 2.17% ↑0.12.12% ↓0.02.12%
Promoters 68.72% 68.72% 68.72% 68.48% ↓0.268.09% ↓0.468.04% ↓0.067.98% ↓0.167.82% ↓0.267.77% ↓0.067.65% ↓0.167.54% ↓0.167.39% ↓0.2
Public 30.34% 30.07% ↓0.330.07% 30.16% ↑0.130.33% ↑0.230.01% ↓0.329.63% ↓0.430.10% ↑0.530.11% 30.12% ↑0.030.25% ↑0.130.34% ↑0.1
No. of Shareholders 14,08413,78216,04115,78516,28215,74815,63318,47121,08522,89924,65324,895

Documents

Frequently Asked Questions about Jagsonpal Pharmaceuticals Ltd

What does Jagsonpal Pharmaceuticals Ltd do?
Incorporated in 1978, Jagsonpal Pharmaceuticals Ltd manufactures and trades pharmaceutical products and active pharmaceutical ingredients[1]
Where is Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) listed?
Jagsonpal Pharmaceuticals Ltd is listed on the Indian stock exchanges. It is listed on NSE: JAGSNPHARM and BSE: 507789. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Jagsonpal Pharmaceuticals Ltd belong to?
Jagsonpal Pharmaceuticals Ltd operates in the Healthcare sector within the Pharmaceuticals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Jagsonpal Pharmaceuticals Ltd?
Jagsonpal Pharmaceuticals Ltd has a market capitalisation of approximately ₹1235.47 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Jagsonpal Pharmaceuticals Ltd?
The Price-to-Earnings (PE) ratio of Jagsonpal Pharmaceuticals Ltd is 30.30. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Jagsonpal Pharmaceuticals Ltd?
Over the past 52 weeks, Jagsonpal Pharmaceuticals Ltd has traded between a low of ₹1,548 and a high of ₹1,851.2. This range helps investors understand the stock's price volatility and recent trading levels.
Does Jagsonpal Pharmaceuticals Ltd pay dividends?
Yes, Jagsonpal Pharmaceuticals Ltd has a dividend yield of 1.34%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
How can I research Jagsonpal Pharmaceuticals Ltd on Tapetide?
On Tapetide, you can view Jagsonpal Pharmaceuticals Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Incorporated in 1978, Jagsonpal Pharmaceuticals Ltd manufactures and trades pharmaceutical products and active pharmaceutical ingredients[1]

Website jagsonpal.com
CEO Mr. Manish Gupta
Employees 1,399
Listed 2000-03-01
Face Value ₹ 2
Issued Size 6,67,81,270